The company is investing around E30m in planning, developing and constructing the plant, which will produce active ingredients and excipients, products for use in biopharmaceutical production processes, additives
VersaFilm is IntelGenx’s immediate release wafer technology. It is comprised of a thin polymeric film using United States Pharmacopeia (USP) components, that are safe and approved by the
Sean Scott, senior vice president of commercial operations at Ingenuity Systems, said: “Ingenuity is excited to partner with SeouLin Bioscience – they are a recognized leader in Korea
Patients who had received placebo treatment experienced a 0.22% HbA1c reduction, six months post-treatment. Post prandial and AUC (area under the curve) glucose showed improvement versus placebo but
The FDA requested additional data which the company expects to submit in the third quarter of 2010. The agency did not request any additional efficacy studies. Rajesh Shrotriya,
IsoRay Medical, in conjunction with its Canadian distribution partner, Inter V Medical, looks forward to expand the application of Cesium-131 for other cancer treatment areas of the body.
Arlene Morris, president and chief executive officer of Affymax, said: “Completion of this comprehensive Hematide program marks a major milestone and we anticipate an intensive period of data
As per the agreement, Penwest is expected to receive undisclosed fees and payments from Otsuka. Jennifer Good, president and CEO of Penwest, said: “We are very pleased to
The allowed claims relate to human microRNA miR-21, a microRNA that is a potential target for a number of therapeutic indications. Regulus has access to the Tuschl III
The company claims that the studies conducted by researchers in the US, including the Centers for Disease Control and Prevention (CDC), showed that antibody-only tests fail to identify
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.